Veradigm | MDRX - Des Atouts





Des Atouts Changement Date
Alcidion AUD 118.08M 2.46M 2025-12
Ambu A/S DKK 8.22B 449M 2026-09
Amplifon EUR 3.6B 328.33M 2026-06
Cardinal Health USD 59.54B 2.24B 2026-09
Centene USD 79.28B 3.73B 2026-09
Charles River Laboratories USD 7.45B 80.64M 2026-09
Cigna USD 157.64B 562M 2026-09
Coloplast 48.8B 429M 2025-12
Convatec Group USD 3.52B 109.3M 2024-12
CVS Health USD 258.08B 4.31B 2026-09
Diasorin EUR 2.9B 26.83M 2026-06
Elevance Health USD 127.8B 1.36B 2026-09
General Electric Aerospace USD 127.2B 477M 2026-09
Gulf Medical Proj AED 1.55B 700K 2026-03
Humana USD 57.28B 89M 2026-09
IQVIA Holdings USD 30.47B 593M 2026-09
Laboratory Of America USD 18.92B 392.3M 2026-09
Max Healthcare Institute Limited 187.22B 14.91B 2026-09
Maximus USD 4.37B 127.6M 2026-06
McKesson USD 92.32B 3.99B 2026-09
Med Life RON 3.34B 76.39M 2026-03
Molina Healthcare USD 15.65B 351M 2026-09
Omnicell USD 2.06B 57.98M 2026-09
Oriola-kd EUR 771.9M 24.6M 2026-09
Owens Minor USD 2.08B 28.5M 2026-09
Quest Diagnostics USD 17.22B 282M 2026-09
Rede D'or Sao Luiz BRL 113.99B 758.28M 2026-09
Siemens Healthineers EUR 46.71B 962M 2026-09
Sonova Holding CHF 5.92B 468.2M 2025-06
Supermax Corporation Bhd MYR 4.27B 146.48M 2026-06
UnitedHealth USD 312.78B 3.06B 2026-09
Veeva Systems USD 9.06B 69.33M 2026-06
Veradigm USD 1.5B 185.94M 2022-12
Xerox USD 8.64B 1.08B 2026-09